medicen paris region - wissenschaft...
Post on 16-Mar-2018
221 Views
Preview:
TRANSCRIPT
1st for pharmaceuticals
2nd in medtech
3rd in biotechnology
1st in public-sector research
Europe’s largest hospital
network (the AP-HP, Paris
Public Hospitals Group)
FIRST European region in the field of life science and
health
Genopole
(69 companies)
Biocitech
(24 companies)
Paris Biotech
Santé
(24 companies)
Biotop
(5 companies)
Cancer Campus
(planned)
PARIS
River Seine
MEDICEN PARIS REGION BIOPARKS
Health SMEs in the Francilian region (around 330)
Distribution by sector (%)Source Survey MEDICEN-CEGEDIM 2012
Academic&
Clinicians
Large companies
SME
Territorial Agencies
Medicen Paris Region Assets:
45% of the Academic Research in Lifesciences, chemistry, ICT is concentratedin Paris area
Medicen Paris Region gathers :o Universities & Academic Institutes
o AP-HP the largest Hospital of Europe forclinical research & trials
o 15 Big Companies (Pharma, devices,biotech)
o 170 SME (Biotech, MedTech, e-Health)
o Institutional actors of local development(City of Paris, Paris Region…)
Active collaborations with :o Other clusters (CapDigital , Systematic,
OpticsValley, SilverValley)
o Technology Transfer Offices (SATT)
Medicen Paris Region : gathering the stakeholders
Translational Medicine
in vitro diagnosis
Imaging systems
Regenerative Medicine and Biomaterials
ICT for Health
Focused on 5 Strategic Domains
Animated through Working Groups gathering SME, Large companies, Academic research and clinicians
With close links and working relationship with other clusters (CapDigital, Systematic for ICT for health for example)
5 Strategic Domains of Actions (SDA)
Collaborative actions
Active collaboration with French Health Competiveness clusters
Enhancing innovation at the interfaces of different Sciences
Active collaboration with technological clusters (ICT, robotics, lasers, optical technologies....)
International Partnerships for:
o Funding of collaborative R&D Projects
o Networking activities
o Business convention BtoB meetings
o Start-up exchanges and soft landing
A collaborative network
CapDigital+Systema cUnifiedWorkingGroupICTforHealth
FinanceInnova onFundraisingforBiotech/Medtech
EurasantéBioFitBusineddconven on
AtlanPoleBiothérapieRegenera veMedicineworkingGroupMabDesign(An body)
CancerBioSantéInterDAS:Transla onnal,ICTforHelathInnoCanwithCancerCampus,MabDesign
EurobiomedInterDAS:InvitrodiagnosisBusinessconven onMabdesign
MinalogicInterDAS:Imaging
LyonBiopôleMabdesign
AlsaceBioValleyInterDas:Imaging&surgerysystems
Cosme cValléeDevtInterna onal
Non-Health clusters
Health clusters
MEDICEN OFFER
R&D Collaborative
Projects’ FactoryPlan Filière
Products’ Factory
227Projects
accredited &financed
883 M€invested
408 M€Public money
invested
International collaborations opportunities
Contacts, visits,
match-making
Workshops, conventions and events
Delegations, B2B meetings,
mentoring witha large Cie
Transnational research calls,
EuropeanProjects
Soft-landing, incubation
programs (on both sides)
International Scope and collaborations
? ?
BIOTOP BerlinBIOMARYLAND
MASSBIO
JAPON/JETRO
ISRAEL
FRENCH TECH HUB
Current Building Prospective
MEDICON VALLEY
?
?
??
?
?
?
Information workshops:
Key trends and opportunities (country focus), experience sharing
Acces to market, Regulation, Success factors for implantation
IP management
Financing
International Visibility, Congress (BIO, MEDICA)
Collaborative R&D projects (H2020, Transnational Calls)
Inter-clusters collaborations (networking, thematic workhops)
Market Intelligence and Economic Development, B2B meetings
Soft – landing, incubation, programs for start-ups
International offer to our Members
top related